This content is PDF only. Please click on the PDF icon to access.
Two papers appearing in a recent issue of the British Medical Journal raise serious doubts about the validity of the current American approach to Hodgkin's disease. Halie and associates (1, 2) make two major points in these papers. First, they describe an abnormal basophilic leukocyte in peripheral blood concentrates from Hodgkin's patients, which they believe indicates dissemination of the disease to the spleen. Second, they propose that splenic lymphoma, as evidenced by these abnormalities, signifies hematogenous spread and that patients with such spread are not properly classified by current staging systems and do poorly after radiation therapy.
Turning first to
Hematogenous Dissemination of Hodgkin's Disease. Ann Intern Med. ;77:810–811. doi: 10.7326/0003-4819-77-5-810
Download citation file:
Published: Ann Intern Med. 1972;77(5):810-811.
Results provided by:
Copyright © 2019 American College of Physicians. All Rights Reserved.
Print ISSN: 0003-4819 | Online ISSN: 1539-3704
Conditions of Use